$AMRN

Amarin Corp Plc\Uk

Nasdaq · Healthcare · Pharmaceutical Preparations · Dublin 2

AMRN chart

What traders are saying about $AMRN

Latest posts

Amarin Corp Plc\Uk news

Amarin Corp Plc\Uk key financials

USD2025202420232022
Revenue$213.6M$228.6M$306.9M$369.2M
Net income-$38.8M-$87.0M-$55.0M-$105.8M
Diluted EPS$-0.09$-0.20$-0.15$-0.26
Total assets (year end)$670.8M$685.3M$831.7M$886.2M
Cash and equivalents (year end)$134.7M$121.0M$199.3M$217.7M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Amarin Corp Plc\Uk

Ticker
AMRN (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Dublin 2
Incorporated in
United Kingdom
Fiscal year end
December 31
SEC CIK
897448
Former names
AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC

Frequently asked questions

What exchange is Amarin Corp Plc\Uk listed on?

Amarin Corp Plc\Uk trades on the Nasdaq under the ticker symbol AMRN.

What industry is Amarin Corp Plc\Uk in?

Amarin Corp Plc\Uk is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Amarin Corp Plc\Uk headquartered?

Amarin Corp Plc\Uk's business address on file with the SEC is in Dublin 2.

When does Amarin Corp Plc\Uk's fiscal year end?

Amarin Corp Plc\Uk's fiscal year ends on December 31.

How much revenue did Amarin Corp Plc\Uk report?

Amarin Corp Plc\Uk reported $213.6M in revenue for calendar year 2025, according to its SEC filings.